Arca
Skip to content
Tools
Tools

-trectinib

Drugs that block TRK kinases, like larotrectinib.

  • Drugs ending in -trectinib: 10
  • Approved somewhere: 3
  • With a US drug page: 3

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-trectinib
Class
Drugs that block TRK kinases, like larotrectinib
Sub-stem of
-tinib: Small molecules that block tyrosine kinases, the switches for many growth signals
Most common targets
Neurotrophic tyrosine kinase receptor (4), ROS1 (3), ALK (1), NTRK1 (1), NTRK2 (1), NTRK3 (1), CD74, ROS1 (1), ROS1, SDC4 (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -trectinib, matched by spelling; those with a US drug page link to it.
Acts on
EntrectinibApprovedNeurotrophic tyrosine kinase receptor, ROS1, ALKNeurotrophic tyrosine kinase receptor inhibitor
LarotrectinibApprovedNeurotrophic tyrosine kinase receptorNeurotrophic tyrosine kinase receptor inhibitor
RepotrectinibApprovedNTRK1, NTRK2, ROS1, NTRK3 and 2 moreNerve growth factor receptor Trk-A inhibitor
AnizatrectinibPhase 2——
BoditrectinibPhase 2——
EmzeltrectinibPhase 2——
TaletrectinibPhase 2ROS1, Neurotrophic tyrosine kinase receptorProto-oncogene tyrosine-protein kinase ROS inhibitor
PaltimatrectinibPhase 1——
SelitrectinibPhase 1Neurotrophic tyrosine kinase receptorNeurotrophic tyrosine kinase receptor inhibitor
ZurletrectinibPhase 1——

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.